2020
DOI: 10.1016/j.phro.2020.05.002
|View full text |Cite
|
Sign up to set email alerts
|

Delivery of magnetic resonance-guided single-fraction stereotactic lung radiotherapy

Abstract: Background and purpose: Single-fraction stereotactic ablative radiotherapy (SABR) is an effective treatment for early-stage lung cancer, but concerns remain about the accurate delivery of SABR in a single session. We evaluated the delivery of single-fraction lung SABR using magnetic resonance (MR)-guidance. Materials and methods: An MR-simulation was performed in 17 patients, seven of whom were found to be unsuitable, largely due to unreliable tracking of small tumors. Ten patients underwent single-fraction SA… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
61
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 68 publications
(61 citation statements)
references
References 47 publications
0
61
0
Order By: Relevance
“…Future studies should evaluate whether such an approach is feasible for central lesions using novel image guidance modalities such as magnetic resonance imaging (MRI), which provides superior soft tissue visualization compared with computed tomography, continuous intrafraction visualization, and daily online adaptive replanning to achieve optimal target and normal organ doses. 30 , 31 …”
Section: Methodsmentioning
confidence: 99%
“…Future studies should evaluate whether such an approach is feasible for central lesions using novel image guidance modalities such as magnetic resonance imaging (MRI), which provides superior soft tissue visualization compared with computed tomography, continuous intrafraction visualization, and daily online adaptive replanning to achieve optimal target and normal organ doses. 30 , 31 …”
Section: Methodsmentioning
confidence: 99%
“…Magnetic resonance-guided radiation therapy (MRgRT) is a new modality in image guided radiotherapy where the target position is determined by magnetic resonance imaging (MRI) in real-time before and during the irradiation. Because of the good MRI soft tissue contrast, this leads to an improved patient positioning and therefore also potentially to improved tumor conformity [1] , [2] , [3] , [4] .…”
Section: Introductionmentioning
confidence: 99%
“…More recent reports have demonstrated the utility of adaptive MRgSBRT for high risk lung tumors, including central lesions, reirradiation, and in patients with interstitial lung disease, resulting in low rates of acute toxicity and promising initial local control [61]. Single fraction MRgSBRT to a total dose of 34 Gy has also been shown to be feasible, with a median delivery time of 39 minutes and a median in-room procedure time of 120 minutes [62].…”
Section: Mri In Radiation Treatmentmentioning
confidence: 99%